RxDoctor Payments Data

Mark Moulton, MD

Orthopaedic Surgery · Muskegon, MINPI 1891758850

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (56.9%), food and beverage and other — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Medical Device Business Services, Inc. at 53.1% of the total. Reporting peaked in 2021 at $9,628 and has fallen 98.9% since, to $104 in 2025.

$14,351in general payments, 2019–2025

Across 118 payments — averaging $121.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$8K
  • Medtronic$6K
  • Depuy Synthes Products, Inc.$507
  • Johnson & Johnson$191
  • Carlsmed, Inc.$160
  • Abbott$55
  • plus $104 from 5 others
$897,825in ownership & investment interests, 2019–2025

Across 7 payments — averaging $128,261 each. An ownership or investment interest held by the physician or an immediate family member.

  • Catalyst Orthoscience$898K

What the payments were for

  • Consulting fees$8,16857%
  • Grants$8506%
  • Travel & lodging$5074%
  • Food & beverage$2,67719%
  • Other$2,15015%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,351 in reported general payments places this provider in the 75th percentile of 829 orthopaedic surgery providers in Michigan.

See all orthopaedic surgery providers in Michigan

Medicare billing

Part B allowed, 2024
$269,971
Medicare patients
304
Services billed
1,930

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib960$17,621
Pregabalin861$12,479
Gabapentin237$3,191
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen428$1,678
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen140$668
Dexamethasone44$337
Diclofenac Sodium14$314
Cyclobenzaprine Hcl63$307
Ibuprofen21$256
Tizanidine Hcl20$167
Tramadol Hcl99$154
Diazepam130$137
Acetaminophen-CodeineAcetaminophen With Codeine14$90
Meloxicam21$47

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Muskegon

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →